In the Healthcare Services segment, attractive investment opportunities are driven by capacity expansion, consolidation amongst service providers, and value creation through service improvement in what continues to be a fragmented and inefficient market. In the Pharma and Medtech segments, PAI seeks to identify companies that stand to benefit from trends towards enhanced consumer choice, improved information available to patients and prevention over treatment.

In the Healthcare sector, PAI has completed the buyouts of Ipsen (speciality pharma) and Ceva (veterinarian pharmaceutical laboratory). The PAI team also contributed to the successful development of Cepa (speciality pharma) as a majority shareholder, as well as Alphamed (private hospitals) and Jouan (bio-instrumentations). PAI also recently completed the acquisition of Cerba European Lab, the French leader in clinical pathology.